Skip to main content

EDITORIAL article

Front. Mol. Biosci.
Sec. Molecular Diagnostics and Therapeutics
Volume 11 - 2024 | doi: 10.3389/fmolb.2024.1466938
This article is part of the Research Topic Liquid Biopsy in Oncology: Opportunity and Challenges View all 6 articles

Editorial: Liquid biopsy in Oncology: Opportunity and Challenges

Provisionally accepted
  • 1 All India Institute of Medical Sciences, Bhopal, Bhopal, India
  • 2 Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, India
  • 3 Institute of Science, Banaras Hindu University, Varanasi, Uttar Pradesh, India
  • 4 Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Essen, North Rhine-Westphalia, Germany
  • 5 Central University of Punjab, Bathinda, Punjab, India

The final, formatted version of the article will be published soon.

    Keywords: liquid biopsy, Early Detection of Cancer, Disease prognosis, personalized medicine, Circulating cell free DNA

    Received: 18 Jul 2024; Accepted: 19 Jul 2024.

    Copyright: © 2024 KUMAR, Singh, Arya, Lueong and Jain. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: ASHOK KUMAR, All India Institute of Medical Sciences, Bhopal, Bhopal, India

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.